Tag: liver disease diagnostics market drivers

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Liver Disease Diagnostics Market From 2025 To 2034?

The liver disease diagnostics market has experienced substantial expansion in recent years. It will grow from $36.26 billion in 2024 to $38.95 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The increase observed in previous periods is due to factors such as the rising incidence of both acute and chronic liver conditions, a growing prevalence of liver diseases, increased alcohol consumption, heightened awareness concerning liver health, and the development of healthcare infrastructure.

The liver disease diagnostics market is projected to experience substantial expansion over the upcoming years. This market is set to reach a valuation of $51.62 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. Several factors are expected to fuel this growth during the forecast period, including the expanding elderly population, increased investment in research and development, a higher volume of biopsy procedures and related diseases, and wider acceptance of telemedicine. Key trends anticipated for this period encompass the emergence of personalized medicine, improvements in diagnostic kits, progress in rapid testing solutions, general technological progress within the healthcare sector, and sophisticated new diagnostic techniques.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Which Drivers Are Impacting The Liver Disease Diagnostics Market?

The projected increase in alcohol intake is expected to propel the future growth of the liver disease diagnostics market. This rise in alcohol consumption is linked to factors such as evolving social norms, greater affordability, widespread availability, and increasing stress or mental health challenges. Liver disease diagnostics are essential for monitoring the impact of alcohol consumption on liver health, assisting in the early detection of liver damage signs like fatty liver, hepatitis, or cirrhosis. For example, in December 2022, information from the National Health Service, an England-based government department, revealed that the percentage of individuals who consumed alcohol in the preceding 12 months increased with age, starting at 62% among those aged 16 to 24, and reaching 85% for individuals aged 55 to 74. Thus, the escalating alcohol consumption is stimulating the expansion of the liver disease diagnostics market.

What Are The Leading Segments Analyzed In The Liver Disease Diagnostics Market?

The liver disease diagnosticsmarket covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests; Imaging; Endoscopy; Biopsy; Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Fibrosis; Cirrhosis; Hepatocellular Carcinoma; Other Diseases

3) By End Users: Hospitals; Laboratories; Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel); Enzyme Tests (ALT, AST, ALP); Genetic Testing; Serological Tests

2) By Imaging: Ultrasound Imaging; CT Scans; MRI; Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD); Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy); Fine Needle Aspiration Biopsy; Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging; Biomarker Testing; Fibrosis Scoring Systems

What Long-Term Trends Will Shape The Future Growth Of The Liver Disease Diagnostics Industry?

Leading firms within the liver disease diagnostics market are concentrating on creating innovative solutions, including non-invasive tools for liver assessment, to enhance the precision and efficiency of diagnostic approaches. Such a non-invasive tool for liver assessment encompasses diagnostic techniques that evaluate hepatic conditions through methods like elastography or blood tests, thereby eliminating the necessity for invasive interventions such as biopsies. As an illustration, in September 2024, City Imaging & Clinical, an Indian diagnostic facility, introduced FibroScan, which is a non-invasive diagnostic instrument for evaluating the liver, designed for the early identification of liver conditions like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This sophisticated technology facilitates quick and precise measurements of hepatic stiffness and fat content, circumventing the need for invasive procedures such as biopsies. The process is swift, generally taking 5 to 15 minutes, and entails positioning a probe on the skin above the liver. This probe emits sound waves that quantify the stiffness of liver tissue, assisting in the assessment of fibrosis or scarring.

Who Are The Key Multinational Companies Dominating The Liver Disease Diagnostics Market?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Liver Disease Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2025, By The Business Research Company

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Liver Disease Diagnostics Market Size From 2025 to 2034?

In recent times, the market size for liver disease diagnostics has seen robust growth. Forecasted to expand from $36.26 billion in 2024 to $38.95 billion in 2025, the compound annual growth rate (CAGR) is projected to be 7.4%. Factors such as an increasing incidence of acute and chronic liver diseases, heightened alcohol consumption, growing awareness about liver health, and improved healthcare infrastructure have contributed significantly to the growth during the preceding period.

Expectations are high for the liver disease diagnostics market, which is predicted to experience significant expansion in the coming years. It is estimated that by 2029, it will reach a value of$51.62 billion, growing at a compound annual growth rate (CAGR) of 7.3%. This expected growth during the forecast period is likely due to factors such as an aging population, higher expenditure on research and development, an increase in biopsy procedures and disease incidences, along with the proliferation of telemedicine. Top trends for this period involve the emergence of personalized healthcare, technological progress in diagnostic kit technology, advancements in rapid testing, an overall technological leap in the healthcare industry, and innovation in diagnostic methodologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

What Are the Core Growth Drivers Propelling the Liver Disease Diagnostics Market Forward?

The surge in alcohol intake is anticipated to spur the expansion of the liver disease diagnostics market in the future. Factors such as evolving societal norms, improved financial accessibility, broader availability, and escalating stress or mental health issues contribute to the rise in alcohol consumption. Liver disease diagnostics play a pivotal role in scrutinizing the effects of alcohol consumption on the liver’s health, thus facilitating the early detection of signs of liver damage such as fatty liver, hepatitis, or cirrhosis. For example, in December 2022, the National Health Service, a government department based in England, reported that the proportion of individuals consuming alcohol in the previous 12 months gradually increased with age, starting at 62% for individuals aged 16 to 24 and peaking at 85% for those aged 55 to 74. As a result, the burgeoning alcohol consumption is steering the growth of the liver disease diagnostics market.

What Segment Types Define the Liver Disease Diagnostics Market Structure?

The liver disease diagnosticsmarket covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests; Imaging; Endoscopy; Biopsy; Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Fibrosis; Cirrhosis; Hepatocellular Carcinoma; Other Diseases

3) By End Users: Hospitals; Laboratories; Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel); Enzyme Tests (ALT, AST, ALP); Genetic Testing; Serological Tests

2) By Imaging: Ultrasound Imaging; CT Scans; MRI; Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD); Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy); Fine Needle Aspiration Biopsy; Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging; Biomarker Testing; Fibrosis Scoring Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theLiver Disease Diagnostics Industry Evolution?

Leading firms in the liver disease diagnostics market are zeroing in on the creation of pioneering solutions like non-invasive utilities for liver assessment, aiming to generate precise and effective diagnostic methods. These non-invasive tools involve diagnostic approaches that discern liver conditions through elastography or blood tests, thus eliminating the requirement for invasive activities such as biopsies. For example, in September 2024, City Imaging & Clinical, a diagnostic center based in India, introduced FibroScan – a non-invasive device for liver assessment. Its purpose is the early identification of liver diseases like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This state-of-the-art technology enables swift and correct measurements of liver stiffness and fat content without resorting to invasive methods like biopsies. The process is swift, usually ranging from 5 to 15 minutes, and entails positioning a probe on the skin above the liver. The probe sends out sound waves, which gauge liver tissue stiffness, aiding in the evaluation of fibrosis or scarring.

View the full report here:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

What Is the Definition of the Liver Disease Diagnostics Market?

Liver disease diagnostics refer to the medical procedures and tests used to identify and assess various liver conditions, including liver cirrhosis, hepatitis, fatty liver disease, and liver cancer. These diagnostic methods often involve blood tests to check liver enzyme levels, imaging techniques like ultrasound or CT scans, and sometimes biopsy procedures to obtain tissue samples.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Liver Disease Diagnostics Market Grown from 2024 to 2025?

The market for diagnosing liver diseases has seen notable expansion in the past few years. We anticipate this market to escalate from $36.26 billion in 2024 to $39.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth during the historic period include increased instances of both acute and chronic liver disorders, a rise in the occurrence of liver diseases, an uptick in alcohol consumption, heightened awareness about liver health, and an expanding healthcare infrastructure.

What Growth Rate Is Anticipated for the Liver Disease Diagnostics Market in the Coming Years?

It is anticipated that the liver disease diagnostics market size will witness significant growth in the upcoming years, projected to reach $52.04 billion by 2029 at a compound annual growth rate (CAGR) of 7.4%. The predicted growth during the forecast period is largely due to factors such as the increase in the elderly population, escalating research & development expenditure, a surge in biopsy procedures and disease incidences, alongside the spread of telemedicine implementation. Key trends for the forecast period encompass the emergence of personalized medicine, progress in diagnostic kit technology, developments in rapid testing, technological evolution in the medical sector, and enhancements in diagnostic techniques.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Who Are the Leading Companies in the Liver Disease Diagnostics Market?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

What Are the Key Drivers of the Liver Disease Diagnostics Market?

The escalating trend of alcohol intake is anticipated to fuel the advancement of the liver disease diagnostics market in the future. The surge in alcohol intake is due to factors like evolving social norms, improved financial capacity, extensive accessibility, and increasing stress or mental health issues. Liver disease diagnostics play a pivotal role in scrutinizing the effects of alcohol consumption on liver wellness, aiding in detecting early indicators of liver damage such as fatty liver, hepatitis, or cirrhosis. For instance, according to the National Health Service, a government department based in England, reported in December 2022, the proportion of individuals who had alcohol in the past year escalated with age, commencing at 62% among individuals aged 16 to 24, peaking at 85% among those aged 55 to 74. Hence, the upward trend in alcohol intake is steering the expansion of the liver disease diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

What Are the Key Market Segments in the Liver Disease Diagnostics Industry?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems

What Are the Latest Trends in the Liver Disease Diagnostics Market?

Prominent firms active within the liver disease diagnostics marketplace are striving to create innovative solutions, like non-invasive equipment for liver evaluation, designed to create more precise and effective diagnostic methods. A non-invasive equipment for liver evaluation is a diagnostic approach that gauges the condition of the liver through techniques such as elastography or blood tests, eliminating the requirement for invasive interventions such as biopsies. For example, in September 2024, City Imaging & Clinical, a diagnostic center based in India, introduced FibroScan, a non-invasive diagnostic apparatus for liver evaluation, targeting early detection of liver diseases like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This cutting-edge technology offers rapid and accurate quantification of liver stiffness and fat content, removing the need for invasive operations like biopsies. The process is swift, typically ranging from 5 to 15 minutes, entails the positioning of a probe on the skin above the liver. The probe releases acoustic waves, which quantifies the stiffness of liver tissue, assisting in evaluating fibrosis or scarring.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

What Are the Key Regional Markets in the Liver Disease Diagnostics Industry?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

This Report Delivers Insight On:

1. How big is the liver disease diagnostics market, and how is it changing globally?

2. Who are the major companies in the liver disease diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the liver disease diagnostics market right now?

4. Which products or customer segments are growing the most in the liver disease diagnostics market?

5. What factors are helping or slowing down the growth of the liver disease diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has The Liver Disease Diagnostics Market Size Shifted, And What Is the Outlook Through 2034?

Over the past few years, the size of the liver disease diagnostics market has shown robust growth. The market, which is expected to expand from $36.26 billion in 2024 to $39.05 billion in 2025, will witness a compound annual growth rate (CAGR) of 7.7%. The expansion in the historic timeframe is thanks to a rise in both acute and chronic liver conditions, a higher prevalence of liver diseases, increased alcohol consumption, enhanced consciousness about liver health, and improvements in healthcare infrastructure.

A significant expansion is anticipated in the liver disease diagnostics market in the forthcoming years, with its worth projected to reach $52.04 billion in 2029, reflecting a compound annual growth rate (CAGR) of 7.4%. This growth during the forecast period can be explained by the escalating number of elderlies, increased spending in research & development, a higher count of biopsy procedures along with diseases, as well as broadening adoption of telemedicine. Notable trends anticipated over the forecast period include the emergence of personalized medicine, technological improvements in diagnostic kits, progress in rapid tests, technological evolution within the healthcare industry, and advancements in diagnostic techniques.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Liver Disease Diagnostics Market?

The rise in alcohol intake is anticipated to stimulate the liver disease diagnostics market’s expansion. Variables such as shifting societal norms, better economic accessibility, more pervasive availability, and escalating stress or mental health issues are contributing to increased alcohol consumption. Diagnostics for liver disease play a vital role in gauging the effects of alcohol on liver health, assisting in the early identification of liver deterioration signs like fatty liver, hepatitis, or cirrhosis. For example, the National Health Service, a government department based in England, stated in December 2022 that the proportion of individuals who drank alcohol in the preceding year grew with age, starting at 62% for those between 16 to 24 and hitting 85% for those between 55 to 74. Consequently, the escalating alcohol intake is propelling the growth of the liver disease diagnostics market.

Which Segments in the Liver Disease Diagnostics Offer the Most Growth?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

What Are the Fastest-Growing Geographies in the Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Liver Disease Diagnostics Market?

Major corporations in the liver disease diagnostics market are prioritizing the development of novel solutions such as non-invasive tools for liver assessment, in order to enhance the precision and efficiency of diagnostics methods. Diagnostics methods assessing liver conditions that circumvent invasive procedures like biopsies and use techniques like elastography or blood tests are what non-invasive liver assessment refers to. For example, City Imaging & Clinical, a diagnostic center based in India, introduced FibroScan in September 2024. It’s a non-invasive tool for liver assessment intended for the early diagnosis of liver diseases like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This state-of-the-art technology enables fast and precise calculation of liver stiffness and fat content, eliminating the necessity for invasive procedures like biopsies. The test is typically quick, ranging from 5 to 15 minutes, and entails placing a probe over the liver on the skin. This probe produces sound waves that gauge the stiffness of the liver tissue, aiding in the assessment of fibrosis or scarring.

View the full report here:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

What Are the Key Elements That Define the Liver Disease Diagnostics Market?

Liver disease diagnostics refer to the medical procedures and tests used to identify and assess various liver conditions, including liver cirrhosis, hepatitis, fatty liver disease, and liver cancer. These diagnostic methods often involve blood tests to check liver enzyme levels, imaging techniques like ultrasound or CT scans, and sometimes biopsy procedures to obtain tissue samples.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theLiver Disease Diagnostics Market?

The liver disease diagnostics market is predicted to grow due to the escalating alcohol consumption habits. Factors contributing to the increased alcohol consumption include changes in societal norms, enhanced economic capabilities, increased accessibility, and heightened stress or mental health issues. Performing diagnostics for liver disease is vital in assessing the effect of alcohol on the liver, and it assists in identifying early symptoms of liver damage such as fatty liver, hepatitis, or cirrhosis. For example, the National Health Service, a government body in England, reported in December 2022 that the percentage of people who drank alcohol in the preceding 12 months increased with age; starting at 62% among the 16 to 24 age group and peaking at 85% among those aged 55 to 74. Hence, the rise in alcohol consumption is a significant factor in the expansion of the liver disease diagnostics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

#What Long-Term Growth Rate is Expected for theLiver Disease Diagnostics Market Between 2025 and 2034?

The market for the diagnosis of liver disease has expanded significantly in the past few years. From being worth $36.26 billion in 2024, it is projected to increase to $39.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The historical growth of this market can be credited to a rise in acute and chronic liver disorders, heightened incidences of liver diseases, an upsurge in alcohol consumption, a growing consciousness about liver health, and a burgeoning healthcare infrastructure.

The market size for liver disease diagnostics is projected to experience substantial growth in the upcoming years, reaching an estimated $52.04 billion by 2029 with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the forecast period include a burgeoning elderly populace, increased investment in research & development, the escalating number of biopsy processes and diseases, and a broader acceptance of telemedicine. Noteworthy trends for this period are the emergence of individualized medicine, advances in diagnostic kit technology, progress in rapid tests, improvements in healthcare sector technology, and innovation in diagnostic methods.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

What Are the Current Market Growth and Trends in theLiver Disease Diagnostics Market That Industry Players Should Watch?

Leading organizations in the field of liver disease diagnostics are lending their focus towards the invention of advanced solutions like non-invasive tools for evaluating the liver, in an effort to create more precise and efficient diagnostic techniques. Non-invasive liver evaluation tools refer to assessment methods that scrutinize liver conditions using modalities such as elastography or blood examination, eliminating the necessity for invasive techniques like biopsies. An example of this advancement happened in September 2024, when an Indian diagnostic center named City Imaging & Clinical launched a non-invasive liver diagnostic tool called FibroScan. This tool’s main aim is to detect liver conditions, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD), at an early stage. This state-of-the-art technology enables fast and precise evaluation of liver stiffness and fat content, eliminating the need for invasive techniques like biopsies. The procedure is swift, typically ranging from 5 to 15 minutes, and involves placing a probe on the skin above the liver. The probe sends out sound waves to measure the stiffness of the liver tissue, which aids in evaluating fibrosis or scarring.

What Are the Major Market Players Making an Impact on theLiver Disease Diagnostics Market Growth?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

How Are the Key Segments of the Liver Disease Diagnostics Market Driving Opportunities and Innovations?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theLiver Disease Diagnostics Market?# Market Expansion?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2025, By The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2025

https://thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/human-liver-model-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the liver disease diagnostics market size evolved in recent years?

The market size of liver disease diagnostics has witnessed a significant expansion in the last few years. It is projected to increase from $36.26 billion in 2024 to a remarkable $39.05 billion in 2025, representing a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this historic growth include the increasing number of acute and chronic liver disease cases, a rise in liver diseases, escalating alcohol consumption, heightened awareness about liver health, and the growth of the healthcare infrastructure.

What are the predictions for the liver disease diagnostics market size in the coming years?

Over the coming years, the market size of liver disease diagnostics is anticipated to witness robust growth. With a compound annual growth rate (CAGR) of 7.4%, it is projected to reach $52.04 billion by 2029. Factors like the surge in the geriatric population, increased funds in research and development, greater number of biopsy procedures and diseases, and heightened telemedicine usage contribute to this growth for the forecasted period. Core trends during this period are expected to be the advent of personalized medicine, technological progression in the creation of diagnostic kits and rapid tests, as well as technological innovation in the healthcare industry and diagnostic procedures.

Get your liver disease diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

What key factors are fueling the growth of the liver disease diagnostics market?

The upward trend in alcohol intake is anticipated to boost the liver disease diagnostics market’s expansion in the future. The rise in alcohol intake can be attributed to changes in societal norms, better affordability, widespread accessibility, as well as escalating stress or mental health issues. Diagnostics for liver disease play a critical role in assessing the implications of alcohol intake on liver health, facilitating the early detection of signs of liver damage such as fatty liver, hepatitis or cirrhosis. For example, December 2022 statistics from the National Health Service, a governmental agency in England, indicated an age-related increase in the percentage of individuals who consumed alcohol in the previous 12 months, beginning at 62% for those between 16 to 24 years and spiking to 85% for individuals aged between 55 to 74 years. Hence, the rising consumption of alcohol is fueling the growth of the liver disease diagnostics market.

How is the global liver disease diagnostics market divided into key segments?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Who are the key firms paving the way for growth in the liver disease diagnostics market?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

Which trends are expected to transform the liver disease diagnostics market?

Major companies operating in the liver disease diagnostics market are focusing on developing innovative solutions, such as non-invasive tools for liver assessment, to develop more accurate and efficient diagnostic methods. A non-invasive tool for liver assessment refers to diagnostic methods that evaluate liver conditions using techniques like elastography or blood tests, avoiding the need for invasive procedures like biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool for liver assessment, aimed at early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology allows for rapid and accurate measurements of liver stiffness and fat content without the need for invasive procedures like biopsies. The procedure is quick, typically lasting 5 to 15 minutes, involving the placement of a probe on the skin over the liver. The probe emits sound waves, which measure liver tissue stiffness, helping assess fibrosis or scarring.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

What regions are contributing significantly to the growth of the liver disease diagnostics market?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2025

https://thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/human-liver-model-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: